Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase NA 17Phase 1 11Phase EARLY_PHASE1 3Phase 3 3Phase 2/3 3Phase 1/2 3

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Radiodermatitis 1Polycystic Ovary Syndrome 1Condylomata Acuminata 1

Interventions

Cisplatin 54Cyclophosphamide 42Fluorouracil 41Oxaliplatin 36Capecitabine 35Docetaxel 34Gemcitabine 32Drug Therapy 32Radiotherapy 31Paclitaxel 25Dexamethasone 23Carboplatin 23Leucovorin 21Etoposide 17Doxorubicin 17Cytarabine 17apatinib 16Methotrexate 16Magnetic Resonance Spectroscopy 14Radiation 13Epirubicin 13Busulfan 13Bevacizumab 13Surgical Procedures, Operative 12Neoadjuvant Therapy 12Letrozole 12Decitabine 12Saline Solution 11Irinotecan 11venetoclax 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × OTHER × Curcumin × Clear all
NCT07278128 2025-12-11

Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial

Tarbiat Modarres University

Phase 2/3 Completed
74 enrolled

Polycystic Ovary Syndrome

NCT06281353 2024-02-28

The Effect of Oral Nanocurcumin as an Adjuvant Therapy for Anogenital Warts: Evaluation of Clinical Improvement, NFĸB, IFN-γ, and FOXP3+TReg From Lesions Tissue

Indonesia University

Phase 2/3 Completed
78 enrolled

Condylomata Acuminata

NCT01246973 2016-03-07

Oral Curcumin for Radiation Dermatitis

University of Rochester

Phase 2/3 Completed
686 enrolled 8 charts

Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡